Our study revealed that the risk score was predictive for unsuccessful anti-tumor immune response stages, encompassing the liberation of cancer cell antigens, initiation and activation processes, and recruitment of CD4 and CD8 T cells (Fig. 6C). The gene discussed is CD8A; the disease is neoplasm.